missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EGFL8 (aa 160-220) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (71%), Rat (71%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-63929 (PA5-63929. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The function remains unknown.
Specifications
Specifications
| Accession Number | Q99944 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 80864 |
| Name | Human EGFL8 (aa 160-220) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | C6orf8; EGF like domain multiple 8; EGFL8; EGF-like domain 8; EGF-like domain-containing protein 8; EGF-like protein 8; EGF-like-domain protein 8; EGF-like-domain, multiple 8; Epidermal growth factor-like protein 8; multiple EGF-like domain protein 8; NG3; NG3 protein; UNQ8752/PRO29920; Vascular endothelial statin-2; VE-statin-2 |
| Common Name | EGFL8 |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu